Glucose Intolerance

The supplied grounding supports glucose intolerance as occurring in diabetes mellitus, other diseases, and malnutrition. Review material also links impaired glucose tolerance to insulin resistance in genetically predisposed individuals exposed to excess caloric intake and reduced physical activity. No single cause is established in the grounding.

The grounding describes glucose intolerance as an abnormal post-load glucose response, with elevated glucose during a glucose tolerance test. In the review literature, impaired glucose tolerance arises when beta cells can no longer compensate for insulin resistance by increasing insulin secretion sufficiently, leading to excessive postprandial hyperglycemia. Oxidative stress is proposed as a pathogenic mechanism linking insulin resistance, impaired glucose tolerance, and progression toward overt diabetes.

The review grounding identifies genetic predisposition, excess caloric intake, and reduced physical activity as factors associated with insulin resistance and impaired glucose tolerance. Obesity or overweight is also discussed in relation to altered GLP-1 secretion and impaired glucose metabolism. The MeSH definition additionally notes association with other diseases and malnutrition, but does not specify them as risk factors in a causal sense.

The supplied grounding does not provide a direct treatment standard for glucose intolerance itself. It does indicate that insulin is co-studied with the condition, and that GLP-1 and its analogs are used pharmacologically in type 2 diabetes, with dietary stimulation of GLP-1 discussed as a potential preventive or synergistic approach for improving glucose metabolism. No specific standard-of-care regimen for glucose intolerance is supported by the grounding.